Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.
Class I - Dangerous 💊 Drugs
Recalled: October 7, 2019 Mylan Laboratories Limited (Sterile Products Division) Prescription Drugs
Nationwide
What Should You Do?
- Check if you have this product: Lot: 7008334, Exp April 2020; 7008417, Exp Oct 2020
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Mylan Laboratories Limited (Sterile Products Division)
- Reason for Recall:
- Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.
Product Codes/Lot Numbers:
Lot: 7008334, Exp April 2020; 7008417, Exp Oct 2020
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0139-2020